140 related articles for article (PubMed ID: 18718063)
1. [Synergistic effects of arsenic trioxide and proteasome inhibitor bortezomib on apoptosis induction in Raji cell line].
He Y; Yang JM; Wang JM; Zhou H; Lü SQ; Hu XX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):794-8. PubMed ID: 18718063
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells: the role of protein kinase Cdelta.
Yan H; Wang YC; Li D; Wang Y; Liu W; Wu YL; Chen GQ
Leukemia; 2007 Jul; 21(7):1488-95. PubMed ID: 17495969
[TBL] [Abstract][Full Text] [Related]
3. [Effect of arsenic trioxide combined with bortezomib on proliferation, apoptosis and beta-catenin level in myeloma cell lines].
Zhou LL; Fu WJ; Yuan ZG; Wang DX; Hou J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):84-8. PubMed ID: 18315906
[TBL] [Abstract][Full Text] [Related]
4. [Effects of bortezomib alone or combined with arsenic trioxide on the apoptosis of Jurkat cells and expression of livin mRNA].
Tan DW; Sun ZQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):898-901. PubMed ID: 21867610
[TBL] [Abstract][Full Text] [Related]
5. [HL-60 cell apoptosis induced by bortezomib alone or in combination with arsenic trioxide in vitro].
Sun QX; Meng FY; Fu YB; Li L; Tian S
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1022-5. PubMed ID: 17666343
[TBL] [Abstract][Full Text] [Related]
6. Effects of arsenic trioxide alone and in combination with bortezomib in multiple myeloma RPMI 8266 cells.
Elmahi AY; Niu C; Li W; Li D; Wang GJ; Hao SS; Cui JW
Asian Pac J Cancer Prev; 2013; 14(11):6469-73. PubMed ID: 24377552
[TBL] [Abstract][Full Text] [Related]
7. [Effects of arsenic trioxide combined with bortezomib on proliferation and apoptosis of K562 cells and their mechanism].
Wu HY; Wang SM; Huang JQ; Hao LM; Li XM; Wei LY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1361-4. PubMed ID: 23257433
[TBL] [Abstract][Full Text] [Related]
8. Effects of arsenic trioxide combined with bortezomib on apoptosis of multiple myeloma cell line KM3 and its mechanisms.
Ge QF; Ouyang GF; Chen Y; Zhang Y; Mu QT; Lu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):112-5. PubMed ID: 22391178
[TBL] [Abstract][Full Text] [Related]
9. [In vitro effect of bortezomib alone or in combination with harringtonine or arsenic trioxide on proliferation and apoptosis of multidrug resistant leukemia cells].
Cai YX; Meng FY; Sun QX; Fu YB; Li L
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):737-40. PubMed ID: 19176009
[TBL] [Abstract][Full Text] [Related]
10. The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide.
Abeltino M; Bonomini S; Bolzoni M; Storti P; Colla S; Todoerti K; Agnelli L; Neri A; Rizzoli V; Giuliani N
Exp Hematol; 2011 Jan; 39(1):55-65. PubMed ID: 20977926
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anticancer effects of arsenic trioxide with bortezomib in mantle cell lymphoma.
Jung HJ; Chen Z; McCarty N
Am J Hematol; 2012 Dec; 87(12):1057-64. PubMed ID: 22965904
[TBL] [Abstract][Full Text] [Related]
12. [Apoptosis of Burkitt's lymphoma Raji cell line induced by bortezomib].
Yang XG; Li XL; Chen YJ; Xie ZX; Peng MY; Huang XC; Huang RX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):592-6. PubMed ID: 19549370
[TBL] [Abstract][Full Text] [Related]
13. [Effect of bortezomib used alone or in combination with arsenic trioxide on HL-60 cell xenograft in nude mice].
Li L; Meng FY; Fu YB; Cai YX; Sun QX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1504-6. PubMed ID: 17959525
[TBL] [Abstract][Full Text] [Related]
14. [Effect of PCI-32765 and bortezomib on proliferation and apoptosis of B-cell tumor cell lines and its mechanisms].
Deng Y; Tao SD; Zhang X; He ZM; Chen Y; Deng ZK; Li YY; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1178-82. PubMed ID: 24156429
[TBL] [Abstract][Full Text] [Related]
15. [STI571 enhances the effect of arsenic trioxide and Velcade on bcr/abl+-CD34+ cell proliferation and apoptosis].
Li CY; Meng FY; Sun QX; Fu YB; Li L; Yi ZS; Song LL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1665-9. PubMed ID: 18024285
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide and bortezomib interact synergistically to induce apoptosis in chronic myelogenous leukemia cells resistant to imatinib mesylate through Bcr/Abl‑dependent mechanisms.
Xu W; Wei W; Yu Q; Wu C; Ye C; Wu Y; Yan H
Mol Med Rep; 2014 Sep; 10(3):1519-24. PubMed ID: 24939418
[TBL] [Abstract][Full Text] [Related]
17. PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells.
Bhalla S; Balasubramanian S; David K; Sirisawad M; Buggy J; Mauro L; Prachand S; Miller R; Gordon LI; Evens AM
Clin Cancer Res; 2009 May; 15(10):3354-65. PubMed ID: 19417023
[TBL] [Abstract][Full Text] [Related]
18. PS-341 or a combination of arsenic trioxide and interferon-alpha inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells.
Abou-Merhi R; Khoriaty R; Arnoult D; El Hajj H; Dbouk H; Munier S; El-Sabban ME; Hermine O; Gessain A; de Thé H; Mahieux R; Bazarbachi A
Leukemia; 2007 Aug; 21(8):1792-801. PubMed ID: 17568816
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells.
Gatti L; Benedetti V; De Cesare M; Corna E; Cincinelli R; Zaffaroni N; Zunino F; Perego P
J Inorg Biochem; 2012 Aug; 113():94-101. PubMed ID: 22717676
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism associated to enhancing the sensitivity of myeloma cells U266 to bortezomib by 2-methoxyestradiol].
Wu SQ; Xu ZZ; Huang HB; Lin J; Zhan R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1424-8. PubMed ID: 22169296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
